Dexamethasone, Neomycin, Polymyxin b

Maxitrol

0.1 % / W/V + 3.5 MG / ML + 6000 UNIT / ML SuspensionCanadaMarketedAuthorised 31 Dec 1963

In other countries

The same active substances on other registers, the same brand first.

MaxitrolBrazil · Novartis Biociencias S.ASame brand
MaxitrolBrazil · Alcon Laboratórios do Brasil Ltda.Same brand
Maxitrol 3.500 Ui/ML + 6.000 Ui/ML + 1 MG/ML Colirio en SuspensiónSpain · 1 mg/ml + 6.000 UI/ml + 3.500 UI/ml · colirio en suspensión · Novartis Europharm LimitedSame brand
Maxitrol 3.500 Ui/ML + 6.000 Ui/ML + 1 MG/ML Colirio en SuspensiónSpain · 1 mg + 6 kilo UI + 3.500 UI · colirio en suspensión · Novartis Farmaceutica S.A.Same brand
Maxitrol ColirioSpain · 1 mg + 6000 UI + 3500 UI · colirio en suspensión · Novartis Europharm LimitedSame brand
MaxitrolNew Zealand · Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin b sulphate 6,000 u per mlSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dexamethasone, Neomycin, Polymyxin b

Maxitrol

0.1 % / W/V + 3.5 MG / ML + 6000 UNIT / ML SuspensionCanadaMarketedAuthorised 31 Dec 1963

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

MaxitrolNew Zealand · Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin b sulphate 6,000 u per g

Maxitrol DropsSaudi Arabia · Siegfried EI Masnou, S.A

Maxitrol DropsSaudi Arabia · Alcon Laboratories

MaxitrolSaudi Arabia · Alcon Couvreur

Maxitrol Sterile Ophthalmic SuspensionSingapore · 1.0 mg/ml + 3500 iu/ml + 6000 iu/ml · solution · Novartis (Singapore) Pte LTD

MaxitrolUnited States · 0.1%; 3.5MG BASE/ML; 10,000 UNITS/ML · suspension/drops · Sandoz

MaxitrolUnited States · 0.1%; 3.5MG BASE/GM; 10,000 UNITS/GM · ointment · Sandoz

DexasporinUnited States · 0.1%; 3.5MG BASE/ML; 10,000 UNITS/ML · suspension/drops · Pharmafair

dexametasona + sulfato de neomicina + sulfato de polimixina BBrazil · Geolab Indústria Farmacêutica S/A

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Dexamethasone, Neomycin, Polymyxin b
Strength: 0.1 % / W/V + 3.5 MG / ML + 6000 UNIT / ML
Dosage form: Suspension
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Dec 1963
Registration: DIN 00042676
Marketing authorisation holder: Novartis Pharmaceuticals Canada INC
ATC code: S01CA01
Group: Sensory organs
Supply: PRESCRIPTION

Dioptrol SuspensionDexamethasone + Neomycin + Polymyxin b · 1 MG / ML + 3.5 MG / ML + 10000 UNIT / ML · SuspensionCanada

Odan-TrolDexamethasone + Neomycin + Polymyxin b · 1 MG / ML + 3.5 MG / ML + 10000 UNIT / ML · SuspensionCanada